17,881 resources
By Version
By Realm
Start Prev Rows 16800 - 17000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm |
---|---|---|---|---|---|---|---|---|
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.5--20200901000000 | GCS_MotorCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.6--20200901000000 | GCS_VerbalCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.22--20200901000000 | SpecialismeCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.18--20200901000000 | InterventieCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.12--20200901000000 | ProductCodeCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.13--20200901000000 | IngredientCodeCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.19--20200901000000 | VerrichtingTypeCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.17--20200901000000 | ProductCodeCodelijsten | active | nl | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.21--20200901000000 | WondWeefselCodelijsten | active | nl | |||
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2FISHMethodVS | BC HER2FISHMethodVS ValueSet | draft | 2018-08 | us | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1213.110 | Corticosteroid Ingredients and Risk of GI Bleeding | active | 2023-12 | us | ||
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byIHCScoreVS | BC HER2byIHCScoreVS ValueSet | draft | 2018-08 | us | ||
hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeVS | BC PositiveNegativeVS ValueSet | draft | 2018-08 | us | ||
hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeIndeterminateVS | BC PositiveNegativeIndeterminateVS ValueSet | draft | 2018-08 | us | ||
hl7.eu.fhir.unicom | R5 | ValueSet/atc-spor-vs | EMA SPOR ATC | draft | 2025-06 | eu | ||
hl7.fhir.us.mcode | R4 | ValueSet/mcode-lansky-play-performance-vs | Lansky Play Performance Status VS | active | cic | 2025-02 | us | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.249 | pralsetinib | active | 2024-06 | us | ||
ch.fhir.ig.ch-epr-fhir | R4 | ValueSet/restricted-http-verb-vs | Restricted HTTP Verb Value Set | active | 2025-05 | ch | ||
hl7.eu.fhir.unicom | R5 | ValueSet/authorised-doseform-vs | EMA SPOR Authorised Dose Form | draft | 2025-06 | eu | ||
hl7.fhir.uv.extensions | R5 | ValueSet/condition-course | Condition Course Codes | trial-use | 2 | pc | 2025-08 | uv |
hl7.fhir.uv.genomics-reporting | R4 | ValueSet/knowledge-base-version-vs | Knowledge Base Version Codes | trial-use | 2 | cg | 2025-06 | uv |
hl7.fhir.us.physical-activity | R4 | ValueSet/pa-goal-target-measure | PA Goal Target Measure Codes | informative | pc | 2024-03 | us | |
hl7.eu.fhir.unicom | R5 | ValueSet/all-units-vs | EMA SPOR All Units Combined | draft | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/record-status-spor-vs | EMA SPOR Record Status | draft | 2025-06 | eu | ||
hl7.terminology | R5 | ValueSet/adverse-event-clinical-research-causality-relatedness | Adverse Event Clinical Research Causality Relatedness | active | 1 | brr | 2023-07 | uv |
hl7.eu.fhir.unicom | R5 | ValueSet/substances-vs | EMA SPOR SMS Substances | draft | 2025-06 | eu | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | ValueSet/vs-action-combination-method | Action Combination Method | draft | 2024-02 | uv | ||
ch.fhir.ig.ch-term | R4 | ValueSet/treatmentreason | Treatment Reason | active | 2025-05 | ch | ||
hl7.fhir.us.odh | R4 | ValueSet/obf-datatype-YesNoVS | Yes No VS | draft | 2020-01 | us | ||
hl7.fhir.cz.core | R4 | ValueSet/cz-dlpatc-vs | Value set of DLP ATC | trial-use | 2 | 2025-01 | cz | |
hl7.fhir.cz.core | R4 | ValueSet/cz-dlplecivelatky-vs | Value set of DLP Lecive latky | trial-use | 2 | 2025-01 | cz | |
hl7.fhir.cz.core | R4 | ValueSet/cz-dlplecivepripravky-vs | Value set of DLP Lecive pripravky | trial-use | 2 | 2025-01 | cz | |
hl7.fhir.cz.core | R4 | ValueSet/cz-dlpformy-vs | Value set of DLP formy | trial-use | 2 | 2025-01 | cz | |
hl7.fhir.cz.core | R4 | ValueSet/cz-nclpmat-vs | Value set of NCLP MAT | trial-use | 2 | 2025-01 | cz | |
uk.nhsdigital.r4.test | R4 | ValueSet/a6876ad9-6ac5-431a-980d-b093a07e84d6 | ServiceRequestCategory | draft | 2022-03 | |||
hl7.fhir.us.pq-cmc-fda | R5 | ValueSet/cmc-comp-section-types-vs | eCTD sections Terminology | trial-use | 2 | brr | 2025-07 | us |
hl7.terminology | R5 | ValueSet/adverse-event-clinical-research-grades | Adverse Event Clinical Research Grades | active | 1 | brr | 2023-07 | uv |
hl7.fhir.eu.hdr | R4 | ValueSet/admission-voluntary-status-vs | Encounter Voluntary Status Value Set | draft | 1 | 2025-06 | eu | |
hl7.terminology | R5 | ValueSet/v3-xAdverseEventCausalityAssessmentMethods | x_AdverseEventCausalityAssessmentMethods | active | 2014-03 | uv | ||
hl7-france-fhir.administrative | R4 | ValueSet/fr-related-person | fr-related-person | active | 2021-09 | |||
hl7-france-fhir.administrative | R4 | ValueSet/fr-related-person-role | fr-related-person-role | active | 2021-09 | |||
hl7-france-fhir.administrative | R4 | ValueSet/fr-practitioner-role-categorie-professionnelle | fr-practioner-role-categorie-professionnelle | draft | 2019-12 | |||
hl7-france-fhir.administrative | R4 | ValueSet/fr-practitioner-role-exercice | fr-practioner-role-exercice | active | 5 | pc | 2019-10 | |
hl7.fhir.us.pco | R4 | ValueSet/pco-goal-domain-categories | PCO Goal Domain Categories | draft | 2 | pc | 2025-08 | us |
hl7.fhir.fr.core | R4 | ValueSet/fr-core-vs-cog-commune-pays | FR Core ValueSet COG commune pays | active | 2024-09 | fr | ||
hl7.fhir.dk.core | R4 | ValueSet/sor-organization-type | DK SOR Organization Type | active | 2025-02 | dk | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention | active | 2023-08 | us | ||
hl7.fhir.dk.core | R4 | ValueSet/dk-core-servicerequest-codes | DK codes for ServiceRequest | active | 2025-02 | dk | ||
hl7.fhir.fi.base | R4 | ValueSet/fi-base-restriction-parent-vs | fi-base-restriction-parent-vs | draft | 2025-08 | fi | ||
hl7.fhir.be.terminology | R4 | ValueSet/PSSRatingTypesVS | Types of rating provided by the PSS system | active | 2025-05 | be | ||
hl7.fhir.it.terminology | R4 | ValueSet/vs-V3RoleCode | HL7 Italia - HL7 V3 RoleCode (estensione) | active | 2025-06 | it | ||
hl7.eu.fhir.unicom | R5 | ValueSet/administration-device | EDQM Administration Device | active | 2025-06 | eu | ||
ch.fhir.ig.ch-term | R4 | ValueSet/edqm-administrationmethod | EDQM - Administration Method | active | 2025-05 | ch | ||
hl7.eu.fhir.unicom | R5 | ValueSet/administration-method | EDQM Administration Method | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/basic-dose-form | EDQM Basic Dose Form | active | 2025-06 | eu | ||
hl7.fhir.fr.core | R4 | ValueSet/fr-core-vs-height-body-position | FR Core ValueSet BodyPosition | active | 2024-09 | fr | ||
hl7.eu.fhir.unicom | R5 | ValueSet/closure | EDQM Closure | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/combination-pack | EDQM Combination Pack | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/combined-pharmaceutical-dose-form | EDQM Combined Pharmaceutical Dose Form | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/combined-term | EDQM Combined Term | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/container | EDQM Container | active | 2025-06 | eu | ||
de.fhir.medication | R4 | ValueSet/EDQMUnitOfPresentation | EDQM Unit of Presentation ValueSet | draft | 2025-07 | |||
hl7.eu.fhir.unicom | R5 | ValueSet/intended-site | EDQM Intended Site | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/packaging-category | EDQM Packaging Category | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/patient-friendly-term | EDQM Patient-friendly Term | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/pharmaceutical-dose-form | EDQM Pharmaceutical Dose Form | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/route-of-administration | EDQM Route of Administration | active | 2025-06 | eu | ||
hl7.eu.fhir.unicom | R5 | ValueSet/unit-of-presentation | EDQM Unit of Presentation | active | 2025-06 | eu | ||
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-Hx-UGIB-snomed | Upper gastrointestinal bleed Value Set | draft | cds | 2018-06 | uv | |
hl7.fhir.uv.phd | R4 | ValueSet/ContinuaPHGInterfaces | Continua PHG-HFS Interfaces ValueSet | trial-use | 1 | dev | 2025-08 | uv |
hl7.fhir.uv.phd | R4 | ValueSet/ContinuaPHDInterfaces | Continua PHD-PHG Device Interfaces ValueSet | trial-use | 1 | dev | 2025-08 | uv |
de.basisprofil.r4 | R4 | ValueSet/ValueSet-OPS-SNOMED-Source-Codes | ValueSet of OPS Source Codes for the OPS-SNOMED ConceptMap | active | 2025-06 | |||
fhir.r4.nhsengland.programme | R4 | ValueSet/England-Endpoint-BusinessScenario | England Endpoint Business Scenario | draft | 2025-07 | us | ||
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-renal-LOINC | LOINC Codes for Renal Function | draft | cds | 2018-08 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-digoxin-LOINC | LOINC Codes for Digoxin Concentration | draft | cds | 2018-08 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-aldosterone | Aldosterone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-aspirin | Aspirin Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-betamethasone | Betamethasone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-bromfenac | Bromfenac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-bumetanide | Bumetanide Medications Value Set | draft | cds | 2022-11 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-celecoxib | Celecoxib Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cloprednol | Cloprednol Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cortisone | Cortisone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cortivazol | Cortivazol Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cyclosporine | Cyclosporine Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-deflazacort | Deflazacort Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-desoxycorticosterone | Desoxycorticosterone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-dexamethasone | Dexamethasone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-dexlansoprazole | Dexlansoprazole Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-diclofenac | Diclofenac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-diflunisal | Diflunisal Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-digoxin | Digoxin Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-eplerenone | Eplerenone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-esomeprazole | Esomeprazole Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ethacrynate | Ethacrynate Medications Value Set | draft | cds | 2022-11 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-etodolac | Etodolac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fenoprofen | Fenoprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fludrocortisone | Fludrocortisone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fluocortolone | Fluocortolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-flurbiprofen | Flurbiprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-furosemide | Furosemide Medications Value Set | draft | cds | 2022-11 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-hydrocortisone | Hydrocortisone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ibuprofen | Ibuprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-indomethacin | Indomethacin Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketoprofen | Ketoprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketorolac | Ketorolac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-lansoprazole | Lansoprazole Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-mefenamate | Mefenamate Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-meloxicam | Meloxicam Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-meprednisone | Meprednisone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-methylprednisolone | Methylprednisolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-misoprostol | Misoprostol Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-nabumetone | Nabumetone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-naproxen | Naproxen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-nepafenac | Nepafenac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-omeprazole | Omeprazole Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-oxaprozin | Oxaprozin Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-pantoprazole | Pantoprazole Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-paramethasone | Paramethasone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-piroxicam | Piroxicam Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednisolone | Prednisolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednisone | Prednisone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednylidene | Prednylidene Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-rabeprazole | Rabeprazole Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-rimexolone | Rimexolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-spironolactone | Spironolactone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-sulindac | Sulindac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-tolmetin | Tolmetin Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-torsemide | Torsemide Medications Value Set | draft | cds | 2022-11 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-triamcinolone | Triamcinolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-trilostane | Trilostane Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-warfarin | Warfarin Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-cyclosporine-exclude | Exclude cyclosporine Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-diclofenac-exclude | Exclude Diclofenac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-hydrocortisone-exclude | Exclude Hydrocortisone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-betamethasone-exclude | Exclude Betamethasone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-bromfenac-exclude | Exclude Bromfenac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-dexamethasone-exclude | Exclude Dexamethasone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-fluocortolone-exclude | Exclude Fluocortolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-flurbiprofen-exclude | Exclude Flurbiprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ibuprofen-exclude | Exclude Ibuprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketoprofen-exclude | Exclude Ketoprofen Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-ketorolac-exclude | Exclude Ketorolac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-methylprednisolone-exclude | Exclude Methylprednisolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-nepafenac-exclude | Exclude Nepafenac Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-piroxicam-exclude | Exclude Piroxicam Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-prednisolone-exclude | Exclude Prednisolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-rimexolone-exclude | Exclude Rimexolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-triamcinolone-exclude | Exclude Triamcinolone Medications Value Set | draft | cds | 2018-07 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-topicaldiclofenac | Topical Diclofenac Medications Value Set | draft | cds | 2022-11 | uv | |
hl7.fhir.be.medication | R4 | ValueSet/BeMedicationLineAdherenceStatusReasonVS | Adherence Status Reason ValueSet | active | 2025-07 | be | ||
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-calcium-LOINC | LOINC Codes for Serum Calcium | draft | cds | 2018-08 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-magnesium-LOINC | LOINC Codes for Serum Potassium | draft | cds | 2018-08 | uv | |
hl7.fhir.uv.pddi | R4 | ValueSet/valueset-potassium-LOINC | LOINC Codes for Serum Potassium | draft | cds | 2018-08 | uv | |
fhir.nigeriaImmunization | R4 | ValueSet/IMMZD16-ValueSet | IMMZ.E.DE.5 ValueSet for AEFI Treatment | active | 2025-08 | us | ||
basisprofil.de | R3 | ValueSet/ValueSet-kbv-s-bar2-arztnrfachgruppe | kbv-s-bar2-arztnrfachgruppe | draft | 2017-09 | |||
basisprofil.de | R3 | ValueSet/ValueSet-kbv-s-bar-wbo2 | kbv-s-bar-wbo2 | draft | 2018-11 | |||
de.gematik.isik | R4 | ValueSet/ISiKKernTempSctVS | ISiK Kerntemperatur SnomedCT ValueSet | active | 2025-06 | de | ||
basisprofil.de | R3 | ValueSet/ValueSet-deuev-anlage-7-namenszusaetze | deuev-anlage-7-namenszusaetze | draft | 2017-09 | |||
basisprofil.de | R3 | ValueSet/ValueSet-deuev-anlage-6-vorsatzworte | deuev-anlage-6-vorsatzworte | draft | 2017-09 | |||
de.gematik.isik | R4 | ValueSet/ISiKSpecificKernTempLoincVS | ISiK Specific Kerntemperatur LOINC ValueSet | active | 2025-06 | de | ||
de.gematik.isik | R4 | ValueSet/ISiKSpecificGenericTempLoincVS | ISiK Specific Generische Koerpertemperatur LOINC Konzepte | active | 2025-06 | de | ||
hl7.fhir.uv.phenomics-exchange | R4 | ValueSet/observation-categories | Observation categories | draft | cic | 2024-06 | uv | |
hl7.fhir.uv.phenomics-exchange | R4 | ValueSet/phenotypic-abnormality | Phenotypic abnormality ValueSet | draft | cic | 2024-06 | uv | |
hl7.fhir.uv.phenomics-exchange | R4 | ValueSet/phenotypic-component | Phenotypic component ValueSet | draft | cic | 2024-06 | uv | |
fhir.nigeriaImmunization | R4 | ValueSet/vaccine-diluent-vs | IMMZI - ValueSet for Vacine Stock Levels | active | 2025-08 | us | ||
hl7.fhir.vn.core | R4 | ValueSet/snomedCT-additional-dosage-instruction | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) | draft | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/snomedCT-clinical-finding | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) | draft | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/snomedCT-dosage-administration-route | ValueSet dành cho Đường dùng thuốc (SNOMED CT) | draft | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-medication-code | ValueSet dành cho Mã dược phẩm | draft | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-procedure-code | ValueSet dành cho Mã dịch vụ kỹ thuật | draft | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-core-race | ValueSet dành cho Thông tin dân tộc | active | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-core-occupation | ValueSet dành cho Thông tin nghề nghiệp | active | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-core-education-level | ValueSet dành cho Thông tin trình độ học vấn | active | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-core-ethic | ValueSet dành cho Thông tin tôn giáo | active | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/vn-core-administrative-address | ValueSet dành cho Thông tin địa danh hành chính | active | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/snomedCT-anatomical-body-structure | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) | draft | 2020-12 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/physical-exam-type | ValueSet dành cho loại thăm, khám lâm sàng | active | 2025-07 | vn | ||
hl7.fhir.vn.core | R4 | ValueSet/patient-history-social-factor-type | ValueSet dành cho loại tiền sử bệnh lý và đặc điểm xã hội | active | 2025-07 | vn | ||
fhir.nigeriaImmunization | R4 | ValueSet/neir-substance-vs | NEIR ValueSet for Allowed Allergy-related Substances | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZ.F.DE2 | IMMZ.G.DE2 ValueSet for Client Sex | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/neir-clinical-status-vs | NEIR ValueSet for Clinical Status | active | 2025-08 | us | ||
hl7.fhir.cz.hdr | R4 | ValueSet/cz-consent-category | CZ Consent Category | active | 2025-08 | cz | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZDContraindications | IMMZ.D.DE11 ValueSet for Contraindications | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/DeviceMaterialCodeVS | Device Material ValueSet | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZHDisaggregationGroup | IMMZ.H.DE42 ValueSet for Disaggregation Group | active | 2025-08 | us | ||
hl7.fhir.uv.openehr-test | R5 | ValueSet/openEHR-EHR-OBSERVATION.blood-pressure.v2.at1042 | 24 hour average ValueSet | active | 2025-06 | uv | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZDFacilityType | IMMZ.D.DE2 ValueSet for Facility Type | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/immzc1-hiv-status-vs | IMMZ.C.DE37 ValueSet for HIV Status | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/NEIRImmunizationNotDoneReasonsVS | NEIR ValueSet for Immunization Not Done | active | 2025-08 | us | ||
hl7.fhir.uv.openehr-test | R5 | ValueSet/openEHR-EHR-OBSERVATION.blood-pressure.v2.at1035 | Method ValueSet | active | 2025-06 | uv | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZ.F.DE6 | IMMZ.G.DE6 ValueSet for missed immunization | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/pregnancy-status-vs | IMMZ.C.DE41 ValueSet for Pregnancy Status | draft | 2025-08 | us | ||
hl7.fhir.uv.openehr-test | R5 | ValueSet/openEHR-EHR-OBSERVATION.blood-pressure.v2.at1010 | Diastolic endpoint ValueSet | active | 2025-06 | uv | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZHReportdicaredType | IMMZ.H.DE22 ValueSet for Report Discarded types | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZHReportImprovementIndicator | IMMZ.H.DE34 ValueSet for Report Improvement Indicator | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZDReportIndicatorCode | IMMZ.H.DE10 ValueSet for Report Indicator Code | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZHReportStatus | IMMZ.H.DE2 ValueSet for Report Status | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZHReportType | IMMZ.H.DE10 ValueSet for Report Indicator Code | active | 2025-08 | us | ||
fhir.nigeriaImmunization | R4 | ValueSet/IMMZDRouteOfAdministration | IMMZ.D.DE27 ValueSet for Route of Administration | active | 2025-08 | us |